Related Experiment Video
Updated: Sep 5, 2025
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Key Concepts Surrounding Cardiogenic Shock
Chayakrit Krittanawong1, Mario Rodriguez Rivera2, Preet Shaikh3
1Section of Cardiology, Baylor College of Medicine, Baylor St. Luke's Medical Center, Texas Heart Institute, Houston, TX.
Insights
Cardiogenic shock (CS) remains a critical condition with high mortality, despite advances in treatment. Understanding CS phenotypes and tailored interventions are key to improving patient outcomes.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Cardiogenic shock (CS) is a severe form of circulatory failure due to impaired cardiac performance, leading to organ hypoperfusion.
- It is the most frequent cause of shock in cardiac intensive care units (CICUs) and is associated with significant mortality.
- Despite therapeutic advancements, CS prevalence and mortality rates remain high, with increasing incidence observed in CICUs.
Purpose of the Study:
- To review the key concepts and current understanding of cardiogenic shock.
- To highlight the importance of differentiating CS phenotypes for targeted interventions.
- To discuss current treatment strategies and future research directions for CS management.
Main Methods:
- Review of existing literature and clinical data on cardiogenic shock.
- Analysis of current treatment modalities, including pharmacologic agents and mechanical support.
- Discussion of emerging concepts such as CS phenotypes and their clinical implications.
Main Results:
- CS is characterized by high mortality, although shock related to acute myocardial infarction (AMI) may show declining trends.
- Assessment of CS requires a holistic approach considering hemodynamic, metabolic, inflammatory, and cardiac function.
- Current data suggest norepinephrine as a first-line agent, with limited use of pulmonary artery catheters (PAC) in randomized trials and frequent reliance on intra-aortic balloon pumps (IABP) for mechanical support.
Conclusions:
- CS is a dynamic condition requiring individualized treatment strategies based on specific phenotypes and SCAI SHOCK stages.
- Emergent percutaneous coronary intervention (PCI) of the culprit vessel is recommended for patients with AMI-related CS.
- Further prospective studies are needed to refine phenotyping and guide targeted therapies for cardiogenic shock.
Abstract:
Cardiogenic shock (CS) is the final common pathway of impaired cardiovascular performance that results in ineffective forward cardiac output producing clinical and biochemical signs of organ hypoperfusion. CS represents the most common cause of shock in the cardiac intensive care unit (CICU) and accounts for a substantial proportion of CICU patient deaths. Despite significant advances in revascularization techniques, pharmacologic therapeutics and mechanical support devices, CS remains associated with a high mortality rate. Indeed, the prevalence of CS within the CICU appears to be increasing. CS can be differentiated as phenotypes reflecting different metabolic, inflammatory, and hemodynamic profiles, depending also on anatomic substrate and congestion profile. Future prospective studies and clinical trials may further characterize these phenotypes and apply targeted intervention for each phenotype and SCAI SHOCK stage rather than a one-size-fits-all approach. Overall, there are 8 key concepts of CS; 1) the mortality associated with CS; 2) Shock attributed to AMI may be declining in both incidence and associated mortality; 3) providers should think about hemodynamic, metabolic, inflammation and cardiac function in totality to assess CS; 4) CS is a dynamic process; 5) no randomized trials evaluating use of the PAC in patients with CS; 6) most data supporting neosynephrine as first line agent in CS; 7) most registries suggest that almost half of CS patients do not have any mechanical support, and the vast majority of the remainder utilize the IABP; and 8) patients with AMI CS should receive emergent PCI of the culprit vessel.
Related Concept Videos
01:24Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
01:30Introduction Cardiac Emergencies
01:17Pathophysiology of Heart Failure
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
01:26Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
01:27Heart Failure I: Introduction